Table 3.
Intervention Phase (Baseline to 6-month) | Maintenance Phase (6-month to 12-month) | |||||
---|---|---|---|---|---|---|
Outcome measures | INTERVENTION (n = 83) |
CONTROL (n = 66) |
Between group difference b | INTERVENTION (n = 65) |
CONTROL (n = 56) |
Between group difference b |
Changes within group a | Changes within group a | |||||
Mean difference (95% CI) |
Mean difference (95% CI) |
Mean difference (95% CI) |
Mean difference (95% CI) |
|||
Body fat mass (kg) | −1.20 | −1.14 | 0.892 | 0.48 | 0.59 | 0.764 |
(−1.76, −0.64) | (− 1.68, − 0.60) | (0.07, 0.89) | (− 0.02, 1.19) | |||
< 0.001** | < 0.001** | 0.022 | 0.058 | |||
Body fat percentage (%) | −1.41 | −0.79 | 0.226 | 0.53 | 0.35 | 0.751 |
(−2.25, −0.57) | (−1.22, − 0.36) | (− 0.41, 1.47) | (− 0.19, 0.88) | |||
0.001* | 0.001* | 0.267 | 0.196 | |||
Skeletal muscle mass (kg) | 0.05 | −0.14 | 0.202 | 0.32 | 0.00 | 0.016* |
(−0.18, 0.28) | (−0.30, 0.02) | (0.17, 0.47) | (−0.23, 0.23) | |||
0.646 | 0.096 | < 0.001** | 0.988 | |||
Visceral fat area (cm2) | − 4.41 | − 4.57 | 0.909 | 2.01 | 1.56 | 0.712 |
(−6.06, −2.76) | (−6.82, −2.31) | (0.51, 3.51) | (−0.44, 3.55) | |||
< 0.001** | < 0.001** | 0.010* | 0.123 | |||
Systolic BP (mmHg) | −6.81 | −7.95 | 0.629 | −1.55 | −1.60 | 0.751 |
(−9.72, −3.90) | (−11.69, −4.20) | (−4.22, 1.13) | (−5.12, 1.93) | |||
< 0.001** | < 0.001** | 0.252 | 0.368 | |||
Diastolic BP (mmHg) | −1.71 | −1.73 | 0.993 | −1.52 | −1.24 | 0.981 |
(−3.71, 0.28) | (−4.12, 0.67) | (−3.49, 0.46) | (− 4.05, 1.56) | |||
0.092 | 0.155 | 0.129 | 0.379 |
Mean differences within group are in mean (95% CI), a negative change indicates a fall in average from baseline to 6 months
P-value: *p < 0.01, **p < 0.001
aChanges of body composition variables during intervention or maintenance phase analysed using paired t- test
bDifference of changes of body composition between intervention and control group measured using ANOVA